Eagle Claw Capital Managment, LLC Amgen Inc Transaction History

Eagle Claw Capital Managment, LLC

$598 Million
Q4 2024

A detailed history of Eagle Claw Capital Managment, LLC transactions in Amgen Inc stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 1,325 shares of AMGN stock, worth $418,753. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,325

Previous 1,325 -0.0%

Holding current value

$418,753

Previous $426,000 19.01%

% of portfolio

0.06%

Previous 0.07%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $30,938 - $33,738	-100 Reduced 7.02%	1,325 $426,000
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $67,737 - $82,560	300 Added 26.67%	1,425 $344,000
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $11,451 - $14,550	-50 Reduced 4.26%	1,125 $295,000
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $11,451 - $14,550	50 Added 4.44%	1,175 $308,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $11,535 - $12,837	-50 Reduced 4.26%	1,125 $274,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $29,197 - $32,392	-125 Reduced 9.62%	1,175 $286,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $3,550 - $4,137	-16 Reduced 1.22%	1,300 $323,000
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $3,280 - $4,350	-18 Reduced 1.35%	1,316 $266,000
Q1 2019 May 01, 2019	SELL	$180.87 - $203.88 $9,043 - $10,194	-50 Reduced 3.61%	1,334 $252,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $6,065 - $7,080	34 Added 2.52%	1,384 $269,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,350	1,350 $232,000

Others Institutions Holding AMGN

# of Institutions

3,182

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.

Account

Eagle Claw Capital Managment, LLC Amgen Inc Transaction History